2상모집 중

Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

연구 개요

This study is researching an experimental drug called REGN13335. The study is focused on participants with Pulmonary Arterial Hypertension (PAH). The aim of the study is to see how safe and effective REGN13335 is in participants with PAH who are taking other PAH medicines. The study is looking at several other research questions, including: * What side effects may happen from taking REGN13335 * How much REGN13335 is in the blood at different times * Whether the body makes antibodies against REGN13335 (which could make REGN13335 less effective or could lead to side effects)

스폰서
리드: 리제네론
적응증
Pulmonary Arterial Hypertension (PAH)
중재
REGN13335, Placebo
목표 등록
99
시작일
2026-05-06
완료(예정)
2028-09-17

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.